Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999-2001).
about
Mathematical model to quantify the effects of risk factors on carbapenem-resistant Acinetobacter baumannii.Antibiotic consumption and healthcare-associated infections caused by multidrug-resistant gram-negative bacilli at a large medical center in Taiwan from 2002 to 2009: implicating the importance of antibiotic stewardship.Prevalence of and Risk Factors for Levofloxacin-Resistant E. coli Isolated from Outpatients with Urinary Tract Infection.Relationship between Antimicrobial Consumption and the Incidence of Antimicrobial Resistance in Escherichia coli and Klebsiella pneumoniae Isolates.Meropenem in the treatment of complicated skin and soft tissue infectionsResistance to antimicrobial agents: an update.Treating serious infections: focus on cefepime.The impact of antibiotic management on resistance.Aminoglycoside resistance in Pseudomonas aeruginosa.Efflux-mediated antimicrobial resistance.Appropriate and timely empirical antimicrobial treatment of icu infections--a role for carbapenems.Resistance patterns of multidrug resistant Acinetobacter baumannii in an ICU of a tertiary care hospital, Malaysia.Anatomic, Geographic, and Taxon-Specific Relative Risks of Carbapenem Resistance in the Health Care System of the U.S. Department of DefenseNonconvulsive status epilepticus cases arising in connection with cephalosporins.The importance and future of antimicrobial surveillance studies.Cephalosporin-induced neurotoxicity: clinical manifestations, potential pathogenic mechanisms, and the role of electroencephalographic monitoring.Correlation between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in a medical-surgical intensive care unit.Insights from the Society of Infectious Diseases Pharmacists on antimicrobial stewardship guidelines from the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America.The use of carbapenems in the treatment of serious infections.The Impact of Antibiotic Stewardship Programs in Combating Quinolone Resistance: A Systematic Review and Recommendations for More Efficient Interventions.Sparing carbapenem usage.A permission system for carbapenem use reduced incidence of drug-resistant bacteria and cost of antimicrobials at a general hospital in Japan.Red man syndrome adverse reaction following intravenous infusion of cefepimeAntibiotic Susceptibilities of Pseudomonas aeruginosa Isolated from Blood Samples and Antibiotic Utilization in a University Hospital in Japan.Trends and correlation of antibacterial usage and bacterial resistance: time series analysis for antibacterial stewardship in a Chinese teaching hospital (2009-2013).The in vitro activity of selected defensins against an isolate of Pseudomonas in the presence of human tears.Correlation between rates of carbapenem consumption and the prevalence of carbapenem-resistant Pseudomonas aeruginosa in a tertiary care hospital in Brazil: a 4-year study.Cefepime dosing in the morbidly obese patient population.Differential correlation between rates of antimicrobial drug consumption and prevalence of antimicrobial resistance in a tertiary care hospital in Greece.The utility of hospital antibiograms as tools for guiding empiric therapy and tracking resistance. Insights from the Society of Infectious Diseases Pharmacists.Trends in aminoglycoside use and gentamicin-resistant gram-negative clinical isolates in US academic medical centers: implications for antimicrobial stewardship.Correlation between antimicrobial consumption and resistance among Staphylococcus aureus and enterococci causing healthcare-associated infections at a university hospital in Taiwan from 2000 to 2009.Correlation between antibiotic consumption and resistance of Gram-negative bacteria causing healthcare-associated infections at a university hospital in Taiwan from 2000 to 2009.Cefixime-induced nonconvulsive status epilepticus.Clinical culture surveillance of carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter species in a teaching hospital in Sao Paulo, Brazil: a 7-year study.The pharmacokinetics change of cefepime after Shuanghuanglian injection administration in subjects with the renal damage.
P2860
Q34057420-2502DB27-FF72-4589-A758-F01EEAE3ECBBQ34759062-750070C0-5A10-461C-A2D0-294EFB14D017Q35182408-F3D30975-B1A7-4AD5-A165-1C4FF0ED90DBQ35230461-167C8CBC-3FCF-451E-A64D-12016600A224Q35919254-2FDEDF8B-B351-4D1A-8FCD-51705F687703Q35976850-EB4EF5E4-B48C-4B5C-ACBC-8D8712E58690Q35976856-907E561F-9C39-4662-A18C-6D21EB5091C8Q35976861-7BF8D6D2-4CDC-4B4C-BA32-273396C06A96Q36021296-3649E3F7-E524-4A96-A29B-DED3DE44E3F2Q36138147-82C2D9D8-D7F0-4941-9E14-09AD1F9C37E9Q36219506-E2E0EC2C-4054-46D3-8D52-AE0BC87256BDQ36552901-EF2E6150-3A8C-4153-8D98-A183662DEEB0Q36933117-835A0AAE-8554-40BC-B873-B7668A1D2113Q37049192-5505A1CF-C43B-4852-9C2F-FC8697DCF199Q37247114-49AF43E1-78D8-41BF-BB94-C03E835F5B93Q37334702-CB3D74B4-79D5-44DB-A714-18896B0665E5Q37385015-62BFE7CE-E4FA-4B6B-B64E-612426AE04D2Q37461442-8E98F44F-4069-4255-B91F-7ECB6AF8E6D8Q37555757-F8DBF0E6-57FE-4688-BF4A-17466EFA1A33Q39183151-D54B5724-6BCA-4B4B-B78F-D4383833FF98Q39388468-3BB344EF-3D32-487C-BD8B-7E14B2CD9026Q40158594-B3BC78E0-35C9-41D3-BCB2-92FB4B83EA63Q41183521-4CBCD151-87B3-4840-B063-5C1CC5695B32Q41216050-08661CB5-1FB1-4989-A3F3-65AD1EEDB237Q41610406-407F1A42-7D73-4802-95CA-D459DE59F731Q42842150-3EC7469C-C87A-41E0-8435-F2FFDE1CA882Q43078257-9A4E112F-3582-46EF-99C3-C9F854F28872Q44189639-7B0316A5-8871-4DA8-AC84-3B5F50C298E6Q44654345-5589732F-8790-4B3C-AE51-02DC6B25E973Q44931814-854E2EAC-823B-41A2-843B-6990992D2303Q44975350-D4EBFB0F-1E8A-4B91-9828-333CBE7D6B3CQ46231564-EF65B2B2-AAA4-40B1-8AD6-109263826FFAQ46690359-79FF2FBE-87DB-4C43-A251-C96F7684F277Q50795938-EF460430-3FCD-429F-A411-0B6BA17E0CFFQ51109833-819F680F-9ABC-4EF3-B0C3-071D2DE8C357Q53455227-3BB7F53A-D8BA-4777-8660-E51B0E765BBC
P2860
Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999-2001).
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Antimicrobial usage and resist ...... in North America (1999-2001).
@en
Antimicrobial usage and resist ...... TIC Programme in North America
@nl
type
label
Antimicrobial usage and resist ...... in North America (1999-2001).
@en
Antimicrobial usage and resist ...... TIC Programme in North America
@nl
prefLabel
Antimicrobial usage and resist ...... in North America (1999-2001).
@en
Antimicrobial usage and resist ...... TIC Programme in North America
@nl
P2093
P356
P1476
Antimicrobial usage and resist ...... in North America (1999-2001).
@en
P2093
Alan H Mutnick
Paul R Rhomberg
Ronald N Jones
P304
P356
10.1093/JAC/DKH039
P407
P577
2004-01-07T00:00:00Z